These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 25681263)
1. The costs of managing genital warts in the UK by devolved nation: England, Scotland, Wales and Northern Ireland. Coles VA; Chapman R; Lanitis T; Carroll SM Int J STD AIDS; 2016 Jan; 27(1):51-7. PubMed ID: 25681263 [TBL] [Abstract][Full Text] [Related]
2. The cost of managing genital warts in the UK. Lanitis T; Carroll S; O'Mahony C; Charman F; Khalid JM; Griffiths V; Brown RE Int J STD AIDS; 2012 Mar; 23(3):189-94. PubMed ID: 22581873 [TBL] [Abstract][Full Text] [Related]
3. Costs of detection and treatment of cervical cancer, cervical dysplasia and genital warts in the UK. Brown RE; Breugelmans JG; Theodoratou D; Bénard S Curr Med Res Opin; 2006 Apr; 22(4):663-70. PubMed ID: 16684427 [TBL] [Abstract][Full Text] [Related]
4. Cost of Preventing, Managing, and Treating Human Papillomavirus (HPV)-Related Diseases in Sweden before the Introduction of Quadrivalent HPV Vaccination. Östensson E; Fröberg M; Leval A; Hellström AC; Bäcklund M; Zethraeus N; Andersson S PLoS One; 2015; 10(9):e0139062. PubMed ID: 26398189 [TBL] [Abstract][Full Text] [Related]
5. Cost analysis of Human Papillomavirus-related cervical diseases and genital warts in Swaziland. Ginindza TG; Sartorius B; Dlamini X; Östensson E PLoS One; 2017; 12(5):e0177762. PubMed ID: 28531205 [TBL] [Abstract][Full Text] [Related]
6. Cost of treatment and QALYs lost due to genital warts: data for the economic evaluation of HPV vaccines in the United Kingdom. Woodhall SC; Jit M; Cai C; Ramsey T; Zia S; Crouch S; Birks Y; Newton R; Edmunds WJ; Lacey CJ Sex Transm Dis; 2009 Aug; 36(8):515-21. PubMed ID: 19543143 [TBL] [Abstract][Full Text] [Related]
7. Treatment patterns and associated costs for genital warts in Italy. Merito M; Largeron N; Cohet C; Timelli L; Boselli F; Matteelli A; Naldi L; Vittori G Curr Med Res Opin; 2008 Nov; 24(11):3175-83. PubMed ID: 18851777 [TBL] [Abstract][Full Text] [Related]
8. Determining the cost of genital warts: a study from Ireland. Dee A; Howell F; O'Connor C; Cremin S; Hunter K Sex Transm Infect; 2009 Sep; 85(5):402-3. PubMed ID: 19004863 [TBL] [Abstract][Full Text] [Related]
9. Medical Care Costs Associated with Genital Warts for Commercially Insured US Patients. Dahlstrom KR; Fu S; Chan W; Shelal Z; Ramondetta LM; Lairson DR Pharmacoeconomics; 2018 Nov; 36(11):1355-1365. PubMed ID: 30019118 [TBL] [Abstract][Full Text] [Related]
10. The impact of genital warts: loss of quality of life and cost of treatment in eight sexual health clinics in the UK. Woodhall SC; Jit M; Soldan K; Kinghorn G; Gilson R; Nathan M; Ross JD; Lacey CJ; Sex Transm Infect; 2011 Oct; 87(6):458-63. PubMed ID: 21636616 [TBL] [Abstract][Full Text] [Related]
11. Updates on human papillomavirus and genital warts and counseling messages from the 2010 Sexually Transmitted Diseases Treatment Guidelines. Dunne EF; Friedman A; Datta SD; Markowitz LE; Workowski KA Clin Infect Dis; 2011 Dec; 53 Suppl 3():S143-52. PubMed ID: 22080267 [TBL] [Abstract][Full Text] [Related]
12. Estimation of the incidence of genital warts and the cost of illness in Germany: a cross-sectional study. Hillemanns P; Breugelmans JG; Gieseking F; Bénard S; Lamure E; Littlewood KJ; Petry KU BMC Infect Dis; 2008 Jun; 8():76. PubMed ID: 18518976 [TBL] [Abstract][Full Text] [Related]
13. The health and economic burden of genital warts in a set of private health plans in the United States. Insinga RP; Dasbach EJ; Myers ER Clin Infect Dis; 2003 Jun; 36(11):1397-403. PubMed ID: 12766834 [TBL] [Abstract][Full Text] [Related]
14. The costs of treating external genital warts in England and Wales: a treatment pattern analysis. Langley PC; White DJ; Drake SM Int J STD AIDS; 2004 Aug; 15(8):501-8. PubMed ID: 15307958 [TBL] [Abstract][Full Text] [Related]
15. Genital warts and cost of care in England. Desai S; Wetten S; Woodhall SC; Peters L; Hughes G; Soldan K Sex Transm Infect; 2011 Oct; 87(6):464-8. PubMed ID: 21813567 [TBL] [Abstract][Full Text] [Related]
16. Assessing incidence and economic burden of genital warts with data from a US commercially insured population. Hoy T; Singhal PK; Willey VJ; Insinga RP Curr Med Res Opin; 2009 Oct; 25(10):2343-51. PubMed ID: 19650749 [TBL] [Abstract][Full Text] [Related]
17. [Anogenital warts incidence, medical management and costs in women consulting gynaecologists in France]. Monsonégo J; Breugelmans JG; Bouée S; Lafuma A; Bénard S; Rémy V Gynecol Obstet Fertil; 2007 Feb; 35(2):107-13. PubMed ID: 17270482 [TBL] [Abstract][Full Text] [Related]
18. Epidemiology and cost of treatment of genital warts in Spain. Castellsagué X; Cohet C; Puig-Tintoré LM; Acebes LO; Salinas J; San Martin M; Breitscheidel L; Rémy V Eur J Public Health; 2009 Jan; 19(1):106-10. PubMed ID: 19112075 [TBL] [Abstract][Full Text] [Related]
19. Epidemiology and costs associated with genital warts in Canada. Marra F; Ogilvie G; Colley L; Kliewer E; Marra CA Sex Transm Infect; 2009 Apr; 85(2):111-5. PubMed ID: 18981170 [TBL] [Abstract][Full Text] [Related]
20. Appraisal of the burden of genital warts from a healthcare and individual patient perspective. Scarbrough Lefebvre CD; Van Kriekinge G; Gonçalves MA; de Sanjose S Public Health; 2011 Jul; 125(7):464-75. PubMed ID: 21722930 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]